Evidence map›Paper›PMID 24935922›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Apurinic/apyrimidinic endonuclease 2 regulates the expansion of germinal centers by protecting against activation-induced cytidine deaminase-independent DNA damage in B cells.

Jeroen E J Guikema, Erin K Linehan, Nada Esa, Daisuke Tsuchimoto, Yusaku Nakabeppu, Robert T Woodland, Carol E Schrader

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Apurinic endonuclease-1 preserves neural genome integrity to maintain homeostasis and thermoregulation and prevent brain tumors.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  12. YY1 Regulates the Germinal Center Reaction by Inhibiting Apoptosis.Journal of immunology (Baltimore, Md. : 1950) · 2016
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Jeroen E J GuikemaDepartment of Molecular and Physiological Systems, Immunology and Microbiology Program, University of Massachusetts Medical School, Worcester, MA 01655; Department of Pathology, Academic Medical Center, 1105 AZ, Amsterdam, The Netherlands; and.
Erin K LinehanDepartment of Molecular and Physiological Systems, Immunology and Microbiology Program, University of Massachusetts Medical School, Worcester, MA 01655;
Nada EsaDepartment of Molecular and Physiological Systems, Immunology and Microbiology Program, University of Massachusetts Medical School, Worcester, MA 01655;
Daisuke TsuchimotoDepartment of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan.
Yusaku NakabeppuDepartment of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan.
Robert T WoodlandDepartment of Molecular and Physiological Systems, Immunology and Microbiology Program, University of Massachusetts Medical School, Worcester, MA 01655;
Carol E SchraderDepartment of Molecular and Physiological Systems, Immunology and Microbiology Program, University of Massachusetts Medical School, Worcester, MA 01655; carol.schrader@umassmed.edu.
University of Massachusetts Chan Medical School · USKyushu University · JPAcademic Medical Center · NL

Funding

HIV vaccine development using humanized miceR01AI084800 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WOODLAND, ROBERT THOMAS · 2009 to 2013
$2.0M
DNA Breaks in Class Switch RecombinationR01AI065639 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SCHRADER, CAROL E · 2005 to 2009
$1.3M
AP Endonuclease 2 in hematopoietic stem cell maintenanceR03AI092528 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SCHRADER, CAROL E · 2011 to 2012
$165k
NIAID NIH HHS AI065639NIAID NIH HHS AI092528NIAID NIH HHS AI84800NIAID NIH HHS R01 AI065639NIAID NIH HHS R01 AI084800NIAID NIH HHS R03 AI092528
6 · The paper itself

Abstract

Activation-induced cytidine deaminase (AID) initiates a process generating DNA mutations and breaks in germinal center (GC) B cells that are necessary for somatic hypermutation and class-switch recombination. GC B cells can "tolerate" DNA damage while rapidly proliferating because of partial suppression of the DNA damage response by BCL6. In this study, we develop a model to study the response of mouse GC B cells to endogenous DNA damage. We show that the base excision repair protein apurinic/apyrimidinic endonuclease (APE) 2 protects activated B cells from oxidative damage in vitro. APE2-deficient mice have smaller GCs and reduced Ab responses compared with wild-type mice. DNA double-strand breaks are increased in the rapidly dividing GC centroblasts of APE2-deficient mice, which activate a p53-independent cell cycle checkpoint and a p53-dependent apoptotic response. Proliferative and/or oxidative damage and AID-dependent damage are additive stresses that correlate inversely with GC size in wild-type, AID-, and APE2-deficient mice. Excessive double-strand breaks lead to decreased expression of BCL6, which would enable DNA repair pathways but limit GC cell numbers. These results describe a nonredundant role for APE2 in the protection of GC cells from AID-independent damage, and although GC cells uniquely tolerate DNA damage, we find that the DNA damage response can still regulate GC size through pathways that involve p53 and BCL6.

Indexed as

DNA DamageAICDA (Activation-Induced Cytidine Deaminase)AnimalsApoptosisB-LymphocytesCell CycleCell ProliferationCells, CulturedCytidine DeaminaseDNA-(Apurinic or Apyrimidinic Site) LyaseDNA-Binding ProteinsDNA Breaks, Double-StrandedEndonucleasesFlow CytometryGerminal CenterImmunoglobulin Class SwitchingAICDA (Activation-Induced Cytidine Deaminase)Apex2 protein, mouseBcl6 protein, mouseCytidine DeaminaseDNA-(Apurinic or Apyrimidinic Site) LyaseDNA-Binding ProteinsEndonucleasesMultifunctional EnzymesProto-Oncogene Proteins c-bcl-6Reactive Oxygen SpeciesTumor Suppressor Protein p53

Identifiers

PMID24935922
PMCPMC4105697
OpenAlexW1880594000

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.